Stock A456570 IMGT CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company IMGT Co.,Ltd.

Equities

A456570

KR7456570001

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-11 pm EDT 		5-day change 1st Jan Change
13,190 KRW +1.46% Intraday chart for IMGT Co.,Ltd. +1.46% +59.11%

Business Summary

IMGT Corp Ltd is a Korea-based company principally engaged in the drug delivery system development and sale business. The Company focus on researching and developing of ultrasound-guided therapy technology which utilizes ultrasound and nanoparticle technology. The Company provides IMGT-LPS, IMGT-EMB and IMGT-TSD technologies. IMGT-LPS technology injects ultrasound-sensitive nanoparticles in the form of liposome-wrapped pharmacological substances into body and releases drugs by irradiating ultrasound to the target area. IMGT-EMB is a nanoparticle for chemoembolization of liver cancer and can be injected into cancer area in form of emulsion. IMGT-TSD is a targeted sonodynamic therapy induces immune boosting mechanism by applying ultrasonic stimulation to the cancer area. In addition, the Company engages in the non-invasive treatment devices IMGT-FUS which using focused ultrasound technology.

Sales per Business

KRW in Million2022Weight2023Weight Delta
Image-guided Drug Delivery Systems
100.0 %
102 100.0 % 42 100.0 % -58.57%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
102 100.0 % 42 100.0 % -58.57%

Managers

Managers TitleAgeSince
Hak-Jong Lee CEO
 Chief Executive Officer - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,938,485 2,109,845 ( 42.72 %) 0 42.72 %

Shareholders

NameEquities%Valuation
Hak-Jong Lee
39.49 %
1,950,000 39.49 % 19 M ₩
K2 Investment Partners LLC
10.35 %
511,245 10.35 % 5 M ₩
Korea Investment Partners Co., Ltd.
9.314 %
459,960 9.314 % 4 M ₩
Eun-ah Chung
8.100 %
400,000 8.100 % 4 M ₩
Hyun-cheol Kim
7.492 %
370,000 7.492 % 4 M ₩
Hak-cheol Lee
2.025 %
100,000 2.025 % 967 101 ₩
Jong-soo Lee
2.025 %
100,000 2.025 % 967 101 ₩

Company contact information

IMGT Corp. Ltd.

408, Healthcare Innovation Park 172 Dolma-ro

13605, Seongnam

+

http://www.nanoimgt.com
address IMGT Co.,Ltd.(A456570)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IMGT CO.,LTD. Stock IMGT Co.,Ltd.
+59.11% 44.87M
MODERNA, INC. Stock Moderna, Inc.
+48.43% 56.87B
LONZA GROUP AG Stock Lonza Group AG
+37.15% 39.72B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-5.89% 39.27B
CELLTRION, INC. Stock Celltrion, Inc.
-6.90% 28.73B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.69% 26.21B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-15.70% 19.79B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+31.73% 12.28B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+28.19% 12.23B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.29% 12.12B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A456570 Stock
  4. Company IMGT Co.,Ltd.